Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by quest13on Aug 17, 2012 10:22am

196 Views

Post# 20228748

RE: RE: RE: RE: First Transplant Pouch!!

The Sertolin use takes place after everything is stable to verify that Sertolin can take the place of Standard Anti rejection drugs.

It is very logical to only take one step at a time to make it easy to say what does go right and veryify that each step works before using them all at once.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!